Ann Daus

SVP, Quality

Ann M. Daus, Ph.D., is presently serving as Senior Vice President, Quality for Aurinia.  Dr. Daus joined the company in 2021 as Vice President, Quality, leading all good practice aspects of Quality including quality assurance, quality control, good clinical practices, and drug safety and pharmacovigilance.

Previously, Dr. Daus served as Vice President & Head of Global Quality at Immunovant for one year and Vice President of Global Quality & Regulatory for the Clinical Trials Division at Thermo Fisher Scientific for four years.  With over 28 years of experience, she has held key Quality/Regulatory leadership positions up to the executive level, including her own consulting business, responsible for quality assurance, quality control, microbiology, regulatory, validation, analytical methods development, and protein characterization in start-up, mid and large pharma companies, including Progenitor Cell Therapy/Caladrius, Laureate Biopharma, Imclone Systems, Glaxo/Smith-Kline Beecham and Johnson & Johnson, across the diverse fields of biologics, pharmaceuticals, cell therapy, medical devices, diagnostics and contract manufacturing. 

Dr. Daus earned a B.S. in Medical Technology from Millersville University of Pennsylvania, and both an M.S. in Microbiology and Ph.D. in Microbiology & Molecular Genetics from Rutgers University in New Jersey.